|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
36,440,000 |
Market
Cap: |
347.64(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$9.54 - $9.54 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile SeaSpine Holdings is a medical technology company focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. Co. has a portfolio of orthobiologics and spinal implant solutions, as well as a surgical navigation system to perform fusion procedures in the lumbar, thoracic and cervical spine. Co.'s orthobiologics products consist of a range of bone graft substitutes including spine, hip, and extremities procedures. Co.'s spinal implants portfolio consists of a line of products and image-guided surgical solutions to help spinal fusion in degenerative, minimally invasive surgery, and spinal deformity procedures.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
3,786 |
Total Sell Value |
$0 |
$0 |
$0 |
$30,288 |
Total People Sold |
0 |
0 |
0 |
1 |
Total Sell Transactions |
0 |
0 |
0 |
1 |
End Date |
2024-06-27 |
2024-03-26 |
2023-09-26 |
2022-09-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Henneman John B III |
Director |
|
2016-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
10,010 |
18,903 |
|
- |
|
Fekete Michael |
Director |
|
2016-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
10,010 |
10,010 |
|
- |
|
Sullivan James M |
Director |
|
2016-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
10,010 |
17,230 |
|
- |
|
Essig Stuart |
Director |
|
2016-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
10,010 |
328,946 |
|
- |
|
Valentine Keith |
Chief Executive Officer |
|
2016-05-23 |
4 |
B |
$10.06 |
$50,300 |
D/D |
5,000 |
75,100 |
2.74 |
- |
|
Valentine Keith |
Chief Executive Officer |
|
2016-05-20 |
4 |
B |
$10.25 |
$51,250 |
D/D |
5,000 |
70,100 |
2.74 |
- |
|
Bostjancic John J. |
Chief Financial Officer |
|
2016-05-20 |
4 |
B |
$10.34 |
$44,731 |
D/D |
4,326 |
27,398 |
2.74 |
- |
|
Bostjancic John J. |
Chief Financial Officer |
|
2016-05-19 |
4 |
B |
$10.16 |
$6,848 |
D/D |
674 |
23,072 |
2.74 |
- |
|
Winge John J. |
Vice President, Sales |
|
2016-03-25 |
4 |
D |
$14.08 |
$3,717 |
D/D |
(264) |
9,482 |
|
- |
|
Bostjancic John J. |
Chief Financial Officer |
|
2016-03-25 |
4 |
D |
$14.08 |
$14,502 |
D/D |
(1,030) |
19,588 |
|
- |
|
Winge John J. |
Vice President, Sales |
|
2016-03-24 |
4 |
D |
$14.08 |
$6,012 |
D/D |
(427) |
9,746 |
|
- |
|
Bostjancic John J. |
Chief Financial Officer |
|
2016-03-24 |
4 |
D |
$14.08 |
$19,811 |
D/D |
(1,407) |
20,618 |
|
- |
|
Winge John J. |
Vice President, Sales |
|
2016-03-23 |
4 |
D |
$14.23 |
$2,689 |
D/D |
(189) |
10,173 |
|
- |
|
Bostjancic John J. |
Chief Financial Officer |
|
2016-03-23 |
4 |
D |
$14.23 |
$5,308 |
D/D |
(373) |
22,025 |
|
- |
|
Bostjancic John J. |
Chief Financial Officer |
|
2015-09-02 |
4 |
B |
$14.05 |
$35,125 |
D/D |
2,500 |
22,398 |
2.74 |
- |
|
Baker Brian D. |
VP, Global Operations |
|
2015-08-27 |
4 |
B |
$14.96 |
$68,816 |
D/D |
4,600 |
4,600 |
2.74 |
- |
|
Essig Stuart |
Director |
|
2015-08-20 |
4 |
B |
$15.38 |
$188,021 |
I/I |
12,225 |
65,100 |
2.1 |
- |
|
Valentine Keith |
Chief Executive Officer |
|
2015-08-20 |
4 |
B |
$15.38 |
$188,021 |
D/D |
12,225 |
65,100 |
2.74 |
- |
|
Stephenson Kirtley C. |
Director |
|
2015-08-19 |
4 |
B |
$15.39 |
$149,283 |
I/I |
9,700 |
9,700 |
2.1 |
- |
|
Essig Stuart |
Director |
|
2015-08-19 |
4 |
B |
$15.31 |
$270,390 |
I/I |
17,661 |
52,875 |
2.1 |
- |
|
Valentine Keith |
Chief Executive Officer |
|
2015-08-19 |
4 |
B |
$15.31 |
$270,390 |
D/D |
17,661 |
52,875 |
2.74 |
- |
|
Winge John J. |
VP, Sales |
|
2015-08-18 |
4 |
B |
$15.21 |
$80,841 |
D/D |
5,315 |
10,362 |
2.74 |
- |
|
Essig Stuart |
Director |
|
2015-08-18 |
4 |
B |
$15.32 |
$539,478 |
I/I |
35,214 |
35,214 |
2.1 |
- |
|
Valentine Keith |
Chief Executive Officer |
|
2015-08-18 |
4 |
B |
$15.32 |
$539,478 |
D/D |
35,214 |
35,214 |
2.74 |
- |
|
Integra Lifesciences Holdings Corp |
10% Owner |
|
2015-07-01 |
4 |
D |
$0.00 |
$0 |
I/I |
(10,955,413) |
0 |
|
- |
|
328 Records found
|
|
Page 13 of 14 |
|
|